SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRtw Biotech Regulatory News (RTW)

Share Price Information for Rtw Biotech (RTW)

Share Price is delayed by 15 minutes
Get Live Data
2.21    0.00 (0.00%)
Bid:
2.19
Ask:
2.21
Spread: 0.02 (0.913%)
Market Cap: $714.60m
RTW Live PriceLast checked at - London Stock Exchange

Intraday Rtw Biotech Share Chart

Update research from QuotedData

20 Jan 2023 16:29

RNS Number : 4534N
RTW Venture Fund Limited
20 January 2023
 

 

 

QuotedData's Investment Trust Weekly News Round-up Show - Stephanie Sirota from RTW Venture Fund

On the 20th January, James Carthew talked through the Weekly News and interviewed Stephanie Sirota from RTW Venture Fund - Watch here.

About our Weekly Show:

The best way to enjoy the show is to join our weekly webinar live, at 11 am every Friday, where we discuss the key stories and events in the investment companies' sector over the last week. We also invite a guest every week and give you the opportunity to get answers to your questions.

Click here to view our previous recordings: https://quoteddata.com/events/?past=true

Click here to view our upcoming events: https://quoteddata.com/events/

This information is also available free on our website www.quoteddata.com where you will also find news, performance data and factsheets on every London listed Investment Company. QuotedData writes and distributes research on a number of quoted companies, facilitates meetings between those companies and existing and potential investors and assists in raising additional capital where required.

This website is for information purposes only and is not intended to encourage the reader to deal in any mentioned securities. QuotedData is a trading name of Marten & Co Limited, which is authorised and regulated by the Financial Conduct Authority. Some of the content in this website is sponsored and, although it abides by Content Principles and Objectives, (/about-quoteddata/research-principles-objectives/) it is considered non-independent. Investments may involve a significant degree of risk, including loss of capital. The value of an investment and the income from it could go down as well as up. The return of your investment is not guaranteed, and you may get back less than you originally invested. Past performance is not an indicator of future performance. It is important that you read the Terms and Conditions (/about-quoteddata/terms-and-conditions/) before considering any investment.

QUOTEDDATA50 Gresham Street | London | EC2V 7AY | UKTel: +44 (0) 20 3691 9430

www.quoteddata.com | research@quoteddata.com | www.martenandco.com

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.Reach is a non-regulatory news service. By using this service an issuer is confirming that the information contained within this announcement is of a non-regulatory nature. Reach announcements are identified with an orange label and the word “Reach” in the source column of the News Explorer pages of London Stock Exchange’s website so that they are distinguished from the RNS UK regulatory service. Other vendors subscribing for Reach press releases may use a different method to distinguish Reach announcements from UK regulatory news.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRAURANROVUAUAR
Date   Source Headline
30th Apr 20257:00 amRNSJade Biosciences merges with Aerovate Therapeutics
29th Apr 20257:00 amRNSTransaction in Own Shares
28th Apr 20257:00 amRNSTransaction in Own Shares
25th Apr 20257:00 amRNSTransaction in Own Shares
22nd Apr 20257:00 amRNSTransaction in Own Shares
17th Apr 20251:30 pmRNSAnnual Financial Report
16th Apr 20257:00 amRNSTransaction in Own Shares
14th Apr 20257:01 amRNSTransaction in Own Shares
14th Apr 20257:00 amRNSMonthly Valuation Update and Factsheet
10th Apr 202512:30 pmRNSDirector/PDMR Shareholding
10th Apr 20257:00 amRNSTransaction in Own Shares
9th Apr 20257:00 amRNSTransaction in Own Shares
7th Apr 20257:00 amRNSTransaction in Own Shares
3rd Apr 202512:30 pmRNSNew Investment in AIRNA
2nd Apr 20257:00 amRNSTransaction in Own Shares
1st Apr 20257:00 amRNSTotal Voting Rights
31st Mar 20257:00 amRNSAnnual Financial Report
28th Mar 20257:00 amRNSTransaction in Own Shares
26th Mar 20257:00 amRNSTransaction in Own Shares
21st Mar 20257:00 amRNSTransaction in Own Shares
20th Mar 20257:00 amRNSTransaction in Own Shares
14th Mar 20257:01 amRNSTransaction in Own Shares
14th Mar 20257:00 amRNSMonthly Valuation Update and Factsheet
13th Mar 20257:00 amRNSTransaction in Own Shares
10th Mar 20257:00 amRNSNotice of Annual Results
7th Mar 20257:00 amRNSTransaction in Own Shares
26th Feb 20257:00 amRNSRTW CIO increases position to 15%
25th Feb 20251:00 pmRNSMaterial purchase by CIO of the Investment Manager
17th Feb 20257:00 amRNSDirector/PDMR Shareholding
14th Feb 20257:00 amRNSMonthly Valuation Update and Factsheet
28th Jan 20257:00 amRNSMaterial Update from Portfolio Company
27th Jan 20257:00 amRNSKailera Reports Positive Data in Ph2 Obesity Trial
17th Jan 20257:01 amRNSNew Investment in Series A of Windward Bio
17th Jan 20257:00 amRNSAdditional Investment in Umoja Biopharma
15th Jan 20257:00 amRNSMonthly Valuation Update and Factsheet
14th Jan 20257:00 amRNSAdditional Investment in Numab Therapeutics
10th Jan 20257:00 amRNSNew Investment in Series A of Alesta Therapeutics
30th Dec 20247:00 amRNSCORXEL Announces Two Significant Transactions
20th Dec 202412:15 pmRNSNew Investment in Series A of Ottimo Pharma
13th Dec 20247:00 amRNSMonthly Valuation Update and Factsheet
10th Dec 202412:00 pmRNSHolding(s) in Company
10th Dec 20247:00 amRNSAppointment of Senior Independent Director
15th Nov 20247:00 amRNSCORXEL Announces Acceptance of NDA for Aficamten
14th Nov 20247:00 amRNSMonthly Valuation Update and Factsheet
1st Nov 20242:00 pmRNSNew Investment in Series C Round of Evommune, Inc.
1st Nov 20247:00 amRNSRTW Biotech Opportunities’ 5th Anniversary
14th Oct 20246:12 pmRNSMonthly Valuation Update and Factsheet Replacement
14th Oct 20247:00 amRNSMonthly Valuation Update and Factsheet
3rd Oct 20247:00 amRNSLaunch of Obesity Company Kailera Therapeutics
2nd Oct 20247:00 amRNSNew Investment in Aktis Oncology

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.